Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.
Saved in:
| Title: | Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study. |
|---|---|
| Authors: | de Bruijn A; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Schipper RJ; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Voogd AC; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.; Maastricht University Medical Center, GROW-School for Oncology and Developmental Biology, 6229 HX Maastricht, The Netherlands., Pullens MJJ; Master Advanced Nursing Practice, Faculty of People and Health, Fontys University of Applied Sciences, 5022 DM Tilburg, The Netherlands., Bloemen JG; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands., van Riet YE; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, 7522 NB Enschede, The Netherlands., Vriens BEP; Department of Internal Medicine, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands. |
| Source: | Cancers [Cancers (Basel)] 2024 Dec 16; Vol. 16 (24). Date of Electronic Publication: 2024 Dec 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers16244188 |
